Case Study: cGMP Compliant Primary Isolation, Expansion and Editing of a Novel Cell Therapy for an Oncology Indication
This Case Study demonstrates how the Excellos team successfully carried out process development of a scale up procedure from tissue culture stacks to a commercial bioreactor system.

For this Case Study, the Excellos team demonstrates how a new cell therapy manufacturing methodology was tech transferred to Excellos manufacturing teams in a relatively short timeline as part of initiation of Phase I and Phase II clinical trials with the product. Download the full Case Study to find out more. 

This Case Study has been produced in partnership with Excellos